标题
Linking the future of anticancer metal-complexes to the therapy of tumour metastases
作者
关键词
-
出版物
CHEMICAL SOCIETY REVIEWS
Volume 44, Issue 24, Pages 8818-8835
出版商
Royal Society of Chemistry (RSC)
发表日期
2015-03-28
DOI
10.1039/c5cs00134j
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Activation of p53 mediated glycolytic inhibition-oxidative stress-apoptosis pathway in Dalton's lymphoma by a ruthenium (II)-complex containing 4-carboxy N-ethylbenzamide
- (2015) Raj Kumar Koiri et al. BIOCHIMIE
- Antiangiogenic ruthenium(ii) benzimidazole complexes, structure-based activation of distinct signaling pathways
- (2015) Haoqiang Lai et al. Metallomics
- Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer
- (2014) Scott Kopetz et al. BMC CANCER
- Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer
- (2014) A F Hezel et al. BRITISH JOURNAL OF CANCER
- Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer
- (2014) Z.Y. Jin et al. GENETICS AND MOLECULAR RESEARCH
- Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer
- (2014) N.G. Alkema et al. GYNECOLOGIC ONCOLOGY
- Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin
- (2014) Jennifer M. Scalici et al. GYNECOLOGIC ONCOLOGY
- Preclinical combination therapy of the investigational drug NAMI-A+ with doxorubicin for mammary cancer
- (2014) Alberta Bergamo et al. INVESTIGATIONAL NEW DRUGS
- Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
- (2014) Suzanne Leijen et al. INVESTIGATIONAL NEW DRUGS
- Arene ruthenium(ii) complex, a potent inhibitor against proliferation, migration and invasion of breast cancer cells, reduces stress fibers, focal adhesions and invadopodia
- (2014) Qiong Wu et al. Metallomics
- Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status
- (2014) Shikha Gaur et al. Molecular Cancer
- BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis
- (2014) Mateusz Rytelewski et al. Molecular Oncology
- BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin
- (2014) B T Paul et al. ONCOGENE
- Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
- (2014) Q H Miow et al. ONCOGENE
- Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients
- (2014) Yu-Lin Lin et al. PLoS One
- Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
- (2014) Ileabett M. Echevarría-Vargas et al. PLoS One
- Withaferin A Alone and in Combination with Cisplatin Suppresses Growth and Metastasis of Ovarian Cancer by Targeting Putative Cancer Stem Cells
- (2014) Sham S. Kakar et al. PLoS One
- In vivo anti-tumor activity of the organometallic ruthenium(ii)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
- (2014) Andrea Weiss et al. Chemical Science
- Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
- (2014) Dinesh Vyas et al. OncoTargets and Therapy
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
- (2014) Guiqin Hou et al. Journal of Immunology Research
- Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?
- (2014) Christen L Walters Haygood World Journal of Stem Cells
- Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model
- (2013) Cristina Maria de Souza et al. BIOMEDICINE & PHARMACOTHERAPY
- Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells
- (2013) Hana Janouskova et al. CANCER LETTERS
- Mechanisms Governing Metastatic Dormancy and Reactivation
- (2013) Filippo G. Giancotti CELL
- Effects of chrysin, apigenin, genistein and their homoleptic copper(II) complexes on the growth and metastatic potential of cancer cells
- (2013) Cornelia Spoerlein et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Imaging VCAM-1 as an Indicator of Treatment Efficacy in Metastatic Ovarian Cancer
- (2013) J. M. Scalici et al. JOURNAL OF NUCLEAR MEDICINE
- Impacts of fullerene derivatives on regulating the structure and assembly of collagen molecules
- (2013) Xiaohui Yin et al. Nanoscale
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients
- (2013) Mario Scartozzi et al. PHARMACOGENOMICS
- Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum
- (2013) Kok-Hooi Yew et al. PLoS One
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- (2013) M. Yu et al. SCIENCE
- Role of ABCG2 expression driven by cisplatin in platinum-containing chemotherapy for gastric cancer
- (2013) Qiang Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Docetaxel–cisplatin might be superior to docetaxel–capecitabine in the first-line treatment of metastatic triple-negative breast cancer†
- (2012) Y. Fan et al. ANNALS OF ONCOLOGY
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Anti-metastatic and Anti-angiogenic Properties of Potential New Anti-cancer Drugs Based on Metal Complexes of Selenosemicarbazones
- (2012) Manja Zec et al. Anti-Cancer Agents in Medicinal Chemistry
- CDK1 Hyperphosphorylation Maintenance Drives the Time-course of G2-M Cell Cycle Arrest after Short Treatment with NAMI-A in Kb Cells
- (2012) Alberta Bergamo et al. Anti-Cancer Agents in Medicinal Chemistry
- Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis
- (2012) J Lee et al. BRITISH JOURNAL OF CANCER
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells
- (2012) Jade B. Aitken et al. Metallomics
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
- (2012) Wan Zhang et al. NATURE CELL BIOLOGY
- A family business: stem cell progeny join the niche to regulate homeostasis
- (2012) Ya-Chieh Hsu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Bone Marrow Stromal Cells Modulate Mouse ENT1 Activity and Protect Leukemia Cells from Cytarabine Induced Apoptosis
- (2012) Patricia Macanas-Pirard et al. PLoS One
- Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial
- (2011) A. Flechon et al. ANNALS OF ONCOLOGY
- Developmental and Pathological Angiogenesis
- (2011) Alicia S. Chung et al. Annual Review of Cell and Developmental Biology
- A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells
- (2011) Fabiana A Serrano et al. BMC CANCER
- Macrophage Binding to Receptor VCAM-1 Transmits Survival Signals in Breast Cancer Cells that Invade the Lungs
- (2011) Qing Chen et al. CANCER CELL
- Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia
- (2011) Thomas Schmidt et al. CANCER CELL
- Bone Marrow Stroma-Secreted Cytokines Protect JAK2V617F-Mutated Cells from the Effects of a JAK2 Inhibitor
- (2011) T. Manshouri et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Dialkyl Bisphosphonate Platinum(II) Complex as a Potential Drug for Metastatic Bone Tumor
- (2011) Hidetoshi Nakatake et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
- (2011) Alberta Bergamo et al. DALTON TRANSACTIONS
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
- (2011) T. Shree et al. GENES & DEVELOPMENT
- Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
- (2011) Sergio A. Quezada et al. IMMUNOLOGICAL REVIEWS
- Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial
- (2011) Matthew T Seymour et al. LANCET
- Role of stromal microenvironment in nonpharmacological resistance of CML to imatinib through Lyn/CXCR4 interactions in lipid rafts
- (2011) Y Tabe et al. LEUKEMIA
- Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin
- (2011) Michael Groessl et al. Metallomics
- Fibroblasts Contribute to Melanoma Tumor Growth and Drug Resistance
- (2011) Edward H. Flach et al. MOLECULAR PHARMACEUTICS
- Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
- (2011) Jonathan W. Wojtkowiak et al. MOLECULAR PHARMACEUTICS
- KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma
- (2011) T Jiffar et al. ONCOGENE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation
- (2011) Douglas W. McMillin et al. PLoS One
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Sublethal concentrations of the platinum(II) complex [Pt(O,O′-acac)(γ-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells
- (2010) Antonella Muscella et al. BRITISH JOURNAL OF PHARMACOLOGY
- Gold(III) porphyrin 1a inhibited nasopharyngeal carcinoma metastasis in vivo and inhibited cell migration and invasion in vitro
- (2010) Ching Tung Lum et al. CANCER LETTERS
- Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
- (2010) N. Chan et al. CANCER RESEARCH
- Platinum-DNA Interactions and Subsequent Cellular Processes Controlling Sensitivity to Anticancer Platinum Complexes
- (2010) Saeed Ahmad CHEMISTRY & BIODIVERSITY
- Neoplastic stem cells: Current concepts and clinical perspectives
- (2010) Axel Schulenburg et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
- (2010) N. Ahmed et al. CURRENT CANCER DRUG TARGETS
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma
- (2010) Pasqualino Malandrino et al. ENDOCRINE-RELATED CANCER
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
- (2010) Mitomu Kioi et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
- (2010) Jo Eyles et al. JOURNAL OF CLINICAL INVESTIGATION
- Synthesis, structure and characterization of novel Cd(II) and Zn(II) complexes with the condensation product of 2-formylpyridine and selenosemicarbazide
- (2010) Snežana Bjelogrlić et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Organometallic ruthenium-based antitumor compounds with novel modes of action
- (2010) Wee Han Ang et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of β1-integrin in K562 chronic myelogenous leukemia cell line
- (2010) Wang Guo-Bao et al. LEUKEMIA & LYMPHOMA
- Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
- (2010) Douglas W McMillin et al. NATURE MEDICINE
- Effects of Bone Marrow Stromal Cells and Umbilical Cord Blood-Derived Stromal Cells on Daunorubicin-Resistant Residual Jurkat Cells
- (2010) X. Liang et al. TRANSPLANTATION PROCEEDINGS
- Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
- (2009) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
- (2009) Frederike Lentz et al. ANTI-CANCER DRUGS
- Mechanisms of anti-cancer action and pharmacology of clofarabine
- (2009) Anna Zhenchuk et al. BIOCHEMICAL PHARMACOLOGY
- Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells
- (2009) D L Roberts et al. BRITISH JOURNAL OF CANCER
- Acute myelogenous leukemia
- (2009) Joshua L. Shipley et al. EXPERIMENTAL HEMATOLOGY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine
- (2008) A C Dudley et al. BRITISH JOURNAL OF CANCER
- Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma
- (2008) Youling Gong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- Targeted therapeutics for cancer treatment: major progress towards personalised molecular medicine
- (2008) Paul Workman et al. CURRENT OPINION IN PHARMACOLOGY
- A 1,2-d(GpG) Cisplatin Intrastrand Cross-Link Influences the Rotational and Translational Setting of DNA in Nucleosomes
- (2008) Matthias Ober et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival
- (2008) Bijan Moshaver et al. LEUKEMIA & LYMPHOMA
- Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance
- (2008) Nadine N. Bewry et al. MOLECULAR CANCER THERAPEUTICS
- ATF6 -Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo
- (2008) D. M. Schewe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now